DG
BMY icon

Delek Group’s Bristol-Myers Squibb BMY Stock Holding History

Delek Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$27M Buy
608,325
+348,325
+134% +$16.2M 1.04% 22
2019
Q1 		$12.3M Buy
260,000
+90,000
+53% +$4.48M 0.51% 79
2018
Q4 		$9.07M Buy
+170,000
New +$9.13M 0.41% 87

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Delek Group's BMY Position: Q2 2019 in Review

Delek Group increased its Bristol-Myers Squibb (BMY) stake by 134% in Q2 2019, buying an estimated $16.2M and bringing the position to 608,325 shares worth $27M. The position accounts for 1.04% of the portfolio, ranked #22.

Delek Group first reported a position in BMY in Q4 2018 and has held it in 3 quarters since. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

  • Delek Group held 608,325 shares of Bristol-Myers Squibb worth $27M as of Q2 2019.
  • Delek Group bought 348,325 Bristol-Myers Squibb shares in Q2 2019, an estimated $16.2M.
  • Bristol-Myers Squibb made up 1.04% of Delek Group's portfolio in Q2 2019, its #22 holding.
  • Delek Group first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 3 quarters since.
  • 1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Delek Group's 13F filing for Q2 2019, filed 8 Aug 2019.